These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27235831)

  • 1. Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination.
    Elewa H; Ahmed D; Barnes GD
    Semin Thromb Hemost; 2016 Sep; 42(6):662-70. PubMed ID: 27235831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome].
    Tubaro M; Falaschi G; Colivicchi F
    G Ital Cardiol (Rome); 2018 Oct; 19(10):552-562. PubMed ID: 30281043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology.
    Fukamachi D; Hirayama A; Miyauchi K; Yasuda S; Ogawa H; Ito H; Daida H
    J Cardiol; 2018 Aug; 72(2):113-119. PubMed ID: 29599096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting.
    Reed GW; Cannon CP
    Clin Cardiol; 2013 Oct; 36(10):585-94. PubMed ID: 23873635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy: triple therapy or triple threat?
    Mega J; Carreras ET
    Hematology Am Soc Hematol Educ Program; 2012; 2012():547-52. PubMed ID: 23233633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists.
    Vardi M; Debidda M; Bhatt DL; Mauri L; Cannon CP
    Clin Cardiol; 2014 Feb; 37(2):103-7. PubMed ID: 24672813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation.
    Lou B; Liang X; Wu Y; Deng Y; Zhou B; Yuan Z; She J
    Am J Cardiol; 2018 Aug; 122(4):604-611. PubMed ID: 30205887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.
    Dzeshka MS; Brown RA; Capodanno D; Lip GY
    Interv Cardiol Clin; 2017 Jan; 6(1):91-117. PubMed ID: 27886825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy].
    Franchina AG; Capodanno D
    G Ital Cardiol (Rome); 2020 Feb; 21(2 Suppl 1):26S-33S. PubMed ID: 32134405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
    Rubboli A; Halperin JL; Airaksinen KE; Buerke M; Eeckhout E; Freedman SB; Gershlick AH; Schlitt A; Tse HF; Verheugt FW; Lip GY
    Ann Med; 2008; 40(6):428-36. PubMed ID: 18608125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes.
    Pop C; Țînț D; Petris A
    Rev Cardiovasc Med; 2021 Sep; 22(3):659-675. PubMed ID: 34565068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint.
    Gwyn JCV; Thomas MR; Kirchhof P
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):157-162. PubMed ID: 28329215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis.
    Li JX; Li Y; Yan SJ; Han BH; Song ZY; Song W; Liu SH; Guo JW; Yin S; Chen YP; Xia DJ; Li X; Li XQ; Jin EZ
    Biomed Rep; 2018 Feb; 8(2):138-147. PubMed ID: 29435272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
    Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
    Rubboli A; Agewall S; Huber K; Lip GY
    Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting.
    Wrigley BJ; Tapp LD; Shantsila E; Lip GY
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):290-3. PubMed ID: 20693960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombotic therapy and atrial fibrillation. Dual or triple therapy after acute coronary syndrome and stent?].
    Zeymer U; Zahn R
    Herz; 2014 Nov; 39(7):814-8. PubMed ID: 25336242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.